文献速递艾滋病与性传播感染

吸烟与戒烟对HIV感染者预期寿命的影响:美国建模研究

Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.
PubMed 文献 · J Infect Dis · 2016-11-03

该研究用计算机模拟基于吸烟状态预测HIV感染者预期寿命,采用按年龄和性别分层的死亡数据。40岁进入HIV照护且继续吸烟者较从不吸烟者分别损失6.7年(男)和6.3年(女)预期寿命,进入照护时戒烟可分别挽回5.7年和4.6年。结论认为吸烟对预期寿命的损失可能超过HIV感染本身,戒烟应成为HIV治疗项目的优先事项。

要点

  • 40岁进入照护的HIV吸烟者较从不吸烟者损失约6年余预期寿命。
  • 进入照护时戒烟可挽回约4.6–5.7年预期寿命。

核心结论

  • HIV感染者吸烟导致的预期寿命损失可能超过HIV感染本身,戒烟应成为HIV治疗项目的优先事项。

研究设计与样本

  • 使用HIV疾病与治疗的计算机模拟,基于按吸烟状态分层的年龄和性别别死亡数据预测HIV感染者预期寿命。
  • 模拟基于吸烟状态、性别和初始年龄预测生存,并估算美国约248 000名HIV吸烟者中一定比例戒烟可获得的潜在寿命年。

主要发现

  • 40岁进入HIV照护(平均CD4+ T细胞计数360 cells/µL)且继续吸烟的男性和女性较从不吸烟者分别损失6.7年和6.3年预期寿命。
  • 进入照护时戒烟者分别挽回5.7年和4.6年预期寿命。
  • 戒烟获益更大的相关因素包括较年轻年龄、较高初始CD4+ T细胞计数和完全坚持抗逆转录病毒治疗。
  • 10%–25%的HIV吸烟者戒烟可节省约106 000–265 000年寿命。

关键数值与推荐

  • 当前吸烟者与从不吸烟者非AIDS相关死亡风险比为2.8。
  • 既往吸烟者与从不吸烟者非AIDS相关死亡风险比为1.0–1.8,取决于戒烟年龄。

临床怎么用

  • 在HIV照护中应把戒烟作为优先干预,尤其对较年轻、初始CD4+ T细胞计数较高且坚持抗逆转录病毒治疗者。
  • 对40岁左右进入HIV照护的吸烟者,应告知其吸烟可损失约6年余预期寿命并鼓励进入照护时即戒烟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the United States, >40% of people infected with human immunodeficiency virus (HIV) smoke cigarettes. METHODS: We used a computer simulation of HIV disease and treatment to project the life expectancy of HIV-infected persons, based on smoking status. We used age- and sex-specific data on mortality, stratified by smoking status. The ratio of the non-AIDS-related mortality risk for current smokers versus that for never smokers was 2.8, and the ratio for former smokers versus never smokers was 1.0-1.8, depending on cessation age. Projected survival was based on smoking status, sex, and initial age. We also estimated the total potential life-years gained if a proportion of the approximately 248 000 HIV-infected US smokers quit smoking. RESULTS: Men and women entering HIV care at age 40 years (mean CD4+ T-cell count, 360 cells/µL) who continued to smoke lost 6.7 years and 6.3 years of life expectancy, respectively, compared with never smokers; those who quit smoking upon entering care regained 5.7 years and 4.6 years, respectively. Factors associated with greater benefits from smoking cessation included younger age, higher initial CD4+ T-cell count, and complete adherence to antiretroviral therapy. Smoking cessation by 10%-25% of HIV-infected smokers could save approximately 106 000-265 000 years of life. CONCLUSIONS: HIV-infected US smokers aged 40 years lose >6 years of life expectancy from smoking, possibly outweighing the loss from HIV infection itself. Smoking cessation should become a priority in HIV treatment programs.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Reddy KP, Parker RA, Losina E, et al. Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study. J Infect Dis. 2016. PMID: 27815384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。